Prescription and over-the-counter medication recalls
Drug recalls come from the FDA's drug enforcement reports. They range from a wrong label to a product that could be harmful, and the risk level on each notice is the FDA's own classification. Never stop a prescribed medication on the strength of a recall notice alone — the notice will say whether to return it, and your prescriber or pharmacist decides what replaces it.
4,474 stored notices, reported between Jun 20, 2012 and Sep 9, 2026. Newest first.
Reported Feb 19, 2020
Fentanyl Citrate Inj., USP 100 mcg Fentanyl/2 mL (50 mcg/mL), 2 mL Single-dose Vial, Each Tray contains 25 Vials,…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Pfizer Inc.
2 more products in this recall
FDA (openFDA drug enforcement)
Reported Feb 19, 2020
Ketorolac Trom, 30 mg/1mL Inj. for I.V./I.M. Use, Rx Only, QTY: 1 ml, Repackaged by: RemedyRepack Inc., Indiana, PA…
High riskUsing this product could cause serious injury, illness or death — stop using it now.RemedyRepack Inc.
FDA (openFDA drug enforcement)
Reported Feb 19, 2020
Lamotrigine Tablets, USP, 100 mg, Rx Only, 100-count bottle, Mfd. by: Taro Pharmaceutical Industries Ltd. Haifa Bay,…
High riskUsing this product could cause serious injury, illness or death — stop using it now.Taro Pharmaceuticals U.S.A., Inc.
FDA (openFDA drug enforcement)
Reported Feb 19, 2020
Methylphenidate hydrochloride Extended-Release ablets USP (CII), 18 mg, 100-count bottle, Rx only, Teva Pharmaceuticals…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Teva Pharmaceuticals USA
1 more product in this recall
FDA (openFDA drug enforcement)
Reported Feb 19, 2020
Ethacrynate Sodium for Injection, USP, 50mg/vial, Single Dose Vial, Rx Only, Manufactured by: Cadila Healthcare…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Zydus Pharmaceuticals USA Inc.
FDA (openFDA drug enforcement)
Reported Feb 12, 2020
Minocycline Hydrochloride Extended-Release Tablets, USP, 105 mg*, 30-count bottle, Rx Only, Manufactured by: Alkem…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Ascend Laboratories LLC
1 more product in this recall
FDA (openFDA drug enforcement)
Reported Feb 12, 2020
Atorvastatin Calcium Tablets, USP, 10 mg*, 90-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Graviti Pharmaceuticals Private Limited
FDA (openFDA drug enforcement)
Reported Feb 12, 2020
Pioglitazone and Metformin Hydrochloride Tablets, USP 15 mg/500 mg, Rx Only, 60-count bottle, Manufactured for Macleods…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Macleods Pharma USA Inc.
FDA (openFDA drug enforcement)
Reported Feb 12, 2020
ranitidine hydrochloride, USP ,150 mg tablets a) 14-count bottles ( NDC 43063-844-14); b) 30-count bottles (NDC…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.PD-Rx Pharmaceuticals, Inc.
FDA (openFDA drug enforcement)
Reported Feb 12, 2020
Ranitidine Hydrochloride (powder), USP, Rx only, Spectrum Chemical Mfg Corp., a) 1 gram, b) 5 grams, c) 25 grams, d)100…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Spectrum Laboratory Products
FDA (openFDA drug enforcement)
Reported Feb 12, 2020
Desmopressin Acetate Tablets, 0.1 mg, 100-count bottle, Rx Only, Manufactured by: Actavis Laboratories, Inc. Fort…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Teva Pharmaceuticals USA
1 more product in this recall
FDA (openFDA drug enforcement)
Reported Feb 12, 2020
Clonidine Hydrochloride Tablets, USP 0.1mg, Rx Only, 100-count bottle, Manufactured by: Unichem Laboratories Ltd.…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Unichem Pharmaceuticals USA Inc.
FDA (openFDA drug enforcement)
Reported Feb 5, 2020
Montelukast Sodium Chewable Tablets, 5 mg, 90-count bottles, Rx Only, Manufactured for : Macleods Pharma USA, Inc.…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Macleods Pharma USA Inc.
FDA (openFDA drug enforcement)
Reported Feb 5, 2020
Dimercaptopropanesulfonate Sodium (DMPS), Aqueous injection solution, 50mg/mL 5 mL SDV, Rx only, McGuff Compounding…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.McGuff Compounding Pharmacy Services, Inc.
FDA (openFDA drug enforcement)
Reported Feb 5, 2020
DHEA/Pregnenol One 10.25 MG Cap
Moderate riskThis product could cause temporary or reversible health problems — stop using it.MPRX, Inc. dba Medical Park Pharmacy
17 more products in this recall
FDA (openFDA drug enforcement)
Reported Feb 5, 2020
Nystatin Oral Suspension, USP 100,000 units per mL Cherry/Peppermint Flavor, 16 fl oz (473 mL) Rx Only, pai,…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Pharmaceutical Associates Inc.
FDA (openFDA drug enforcement)
Reported Feb 5, 2020
Walgreens Acne Cleansing Bar, Benzoyl Peroxide 10%, NET WT 4 oz (113 g), 1 bar per carton, Distributed By: Walgreen…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Shandex Personal Care Manufacturing Inc.
FDA (openFDA drug enforcement)
Reported Jan 29, 2020
NETSPOT, (kit for the preparation of Ga 68 dotatate injection) 40 mcg dotatate, For Intravenous Use Only, Rx Only,…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Advanced Accelerator Applications USA, Inc.
FDA (openFDA drug enforcement)
Reported Jan 29, 2020
Ranitidine Tablets, USP 150 mg , a). 4 count bottle (NDC 70934-017-04), b). 20-count bottle (NDC 70934-017-20), c).…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Denton Pharma, Inc.
1 more product in this recall
FDA (openFDA drug enforcement)
Reported Jan 29, 2020
Ranitidine, 150 mg Tablets, a) 7 count, b) 14 count, c) 20 count, d) 30 count, e) 60 count; Rx, Only, H.J. Harkins…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.H J Harkins Company Inc. dba Pharma Pac
FDA (openFDA drug enforcement)
Reported Jan 29, 2020
methylPREDNISolone Sodium Succinate For Injection, USP, 500 mg*/vial, Rx Only, Mfd by: HIKMA FARMACEUTICA (PORTUGAL),…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Hikma Pharmaceuticals USA Inc.
FDA (openFDA drug enforcement)
Reported Jan 29, 2020
Nizatidine Capsules, USP 150 mg, Rx Only, Mylan Pharmaceuticals Inc., NDC 0378-5150-91.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Mylan Pharmaceuticals Inc.
1 more product in this recall
FDA (openFDA drug enforcement)
Reported Jan 29, 2020
Preferred Pharmaceuticals, Inc, Ranitidine Tablets, 150 mg, a) 30 count bottles (NDC: 68788-7388-3), b) 60 count…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Preferred Pharmaceuticals, Inc.
1 more product in this recall
FDA (openFDA drug enforcement)
Reported Jan 29, 2020
Ranitidine 150 mg tablet Original Supplier's NDC 65162-0253-10 Remedy Repackaged NDC 70518-1714-00
Moderate riskThis product could cause temporary or reversible health problems — stop using it.RemedyRepack Inc.
FDA (openFDA drug enforcement)
Free recall alerts
Get alerted about new Medication recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.
Related categories
RecallNow is not a government agency. Every notice above was published by the FDA, USDA FSIS or CPSC and links back to its source. Browse the whole archive.